Murali Srivathsa is President and CEO of Akura Medical and brings over 25 years of leadership experience at both large and small medical device companies. Previously, he was the Divisional Vice President of Global Heart Failure Marketing at Abbott Laboratories, responsible for Mechanical Circulatory Support (HeartMate™), Acute Circulatory Support (CentriMag™), Pulmonary Artery Pressure Monitoring (CardioMEMS™), and Continuum – a national home medical equipment provider. In this role, he rebuilt the marketing team and helped deliver double-digit market share growth.
Before joining Abbott in 2017, Murali was Vice President and General Manager of Cardiac Management Solutions at ZOLL. ZOLL acquired Kyma Medical Technologies, where he served as President and CEO. Prior to Kyma, Murali was the Vice President of Sales, Marketing and Customer Operations at Corventis, a pioneer in wireless technologies for the treatment of cardiovascular disease, which was acquired by Medtronic in 2014.
Earlier in his career, Murali helped bring nascent therapies, such as heart failure leads and delivery systems, wireless CRT-D devices and wireless home monitoring, to market in various marketing and sales roles at both Boston Scientific’s Cardiac Rhythm Management (CRM) and Guidant CRM.
Murali holds a B.E. in Electronics Engineering from Bangalore University, India, an Executive Masters in International Trade from the Indian Institute of Foreign Trade, and an M.B.A. from IMD, Switzerland.
